Indications on suitable scaffold as carrier of stem cells in the alveoloplasty of cleft palate
Authors:
- 6 July 2006
- journal article
- review article
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 33 (8) , 625-629
Abstract
summary Autologous iliac crest bone is used to close the residual alveolar bone defect in cleft palate patients during late mixed dentition. Surgery involves physical and anaesthesiologic risks, long‐time hospitalization, high costs and not always good results (15% failure rate). Alternatives to iliac crest bone grafting are going to be evaluated: synthetic, xenograft and allograft matrices combined with platelet‐rich plasma or recombined bone morphogenic proteins for osteoinductivity are commercially available. These alternatives have not yet been determined to be equivalent to the previous treatment. A new field of research is represented by stem cells, which have been also used to regenerate ischaemic cardiac tissue after heart attack, to treat hypophosphatasia and osteoporosis. Our aim was to use osteoblasts from stem cells to close the residual palate cleft in association with a suitable carrier. Stem cells are expanded in the Aastrom bioreactor, differentiated into osteoblasts and positioned in the bone defect by means of a Spongostan® scaffold. This scaffold has the best characteristics as commercial availability, low cost, good manageability, absence of allergic reactions or other side effects on patient, biocompatibility, imbibition, radiotransparency, reabsorbability and osteoinductivity. Previous studies encourage Spongostan scaffold application.Keywords
This publication has 17 references indexed in Scilit:
- The STRO-1+ Marrow Cell Population Is MultipotentialCells Tissues Organs, 2001
- A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantationBone Marrow Transplantation, 2001
- Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein KinaseJournal of Biological Chemistry, 2000
- Osteopoiesis: The Early Development of Bone CellsCritical Reviews™ in Eukaryotic Gene Expression, 2000
- Marrow‐derived progenitor cell injections enhance new bone formation during distractionJournal of Orthopaedic Research, 1999
- Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cellsJournal of Orthopaedic Research, 1998
- Management of cleft lip and palate.Archives of Disease in Childhood, 1996
- Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cellsBone, 1996
- Transforming growth factor-6 stimulates bone ongrowth: Hydroxyapatite-coated implants studied in dogsActa Orthopaedica, 1996
- Osseous regeneration in the presence of four common hemostatic agentsJournal of Oral and Maxillofacial Surgery, 1992